FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023129208> ?p ?o ?g. }

• W2023129208 endingPage "R32" @default.
• W2023129208 startingPage "R32" @default.
• W2023129208 abstract "Critically ill patients with renal insufficiency are predisposed to both deep vein thrombosis (DVT) and bleeding. The objective of the present study was to evaluate the prevalence, incidence and predictors of DVT and the incidence of bleeding in intensive care unit (ICU) patients with estimated creatinine clearance <30 ml/min. In a multicenter, open-label, prospective cohort study of critically ill patients with severe acute or chronic renal insufficiency or dialysis receiving subcutaneous dalteparin 5,000 IU once daily, we estimated the prevalence of proximal DVT by screening compression venous ultrasound of the lower limbs within 48 hours of ICU admission. DVT incidence was assessed on twice-weekly ultrasound testing. We estimated the incidence of major and minor bleeding by daily clinical assessments. We used Cox proportional hazards regression to identify independent predictors of both DVT and major bleeding. Of 156 patients with a mean (standard deviation) creatinine clearance of 18.9 (6.5) ml/min, 18 had DVT or pulmonary embolism within 48 hours of ICU admission, died or were discharged before ultrasound testing – leaving 138 evaluable patients who received at least one dose of dalteparin. The median duration of dalteparin administration was 7 days (interquartile range, 4 to 12 days). DVT developed in seven patients (5.1%; 95% confidence interval, 2.5 to 10.1). The only independent risk factor for DVT was an elevated baseline Acute Physiology and Chronic Health Evaluation II score (hazard ratio for 10-point increase, 2.25; 95% confidence interval, 1.03 to 4.91). Major bleeding developed in 10 patients (7.2%; 95% confidence interval, 4.0 to 12.8), all with trough anti-activated factor X levels ≤ 0.18 IU/ml. Independent risk factors for major bleeding were aspirin use (hazard ratio, 6.30; 95% confidence interval, 1.35 to 29.4) and a high International Normalized Ratio (hazard ratio for 0.5-unit increase, 1.68; 95% confidence interval, 1.07 to 2.66). In ICU patients with renal insufficiency, the incidence of DVT and major bleeding are considerable but appear related to patient comorbidities rather than to an inadequate or excessive anticoagulant from thromboprophylaxis with dalteparin. Number NCT00138099." @default.
• W2023129208 created "2016-06-24" @default.
• W2023129208 creator A5003250662 @default.
• W2023129208 creator A5007794186 @default.
• W2023129208 creator A5009424802 @default.
• W2023129208 creator A5010437603 @default.
• W2023129208 creator A5011364849 @default.
• W2023129208 creator A5016832904 @default.
• W2023129208 creator A5029656810 @default.
• W2023129208 creator A5030817657 @default.
• W2023129208 creator A5031717153 @default.
• W2023129208 creator A5035524531 @default.
• W2023129208 creator A5041418474 @default.
• W2023129208 creator A5052169179 @default.
• W2023129208 creator A5058197621 @default.
• W2023129208 creator A5069466103 @default.
• W2023129208 creator A5072937016 @default.
• W2023129208 creator A5079941141 @default.
• W2023129208 creator A5082527172 @default.
• W2023129208 creator A5084752934 @default.
• W2023129208 date "2008-01-01" @default.
• W2023129208 modified "2023-10-16" @default.
• W2023129208 title "Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors" @default.
• W2023129208 cites W1509399724 @default.
• W2023129208 cites W1550111394 @default.
• W2023129208 cites W176762677 @default.
• W2023129208 cites W1973391331 @default.
• W2023129208 cites W1980954725 @default.
• W2023129208 cites W1982492833 @default.
• W2023129208 cites W2003812647 @default.
• W2023129208 cites W2013537866 @default.
• W2023129208 cites W2023580217 @default.
• W2023129208 cites W2053861684 @default.
• W2023129208 cites W2062083070 @default.
• W2023129208 cites W2063233064 @default.
• W2023129208 cites W2065379041 @default.
• W2023129208 cites W2082250901 @default.
• W2023129208 cites W2088267193 @default.
• W2023129208 cites W2093890705 @default.
• W2023129208 cites W2094662698 @default.
• W2023129208 cites W2102024150 @default.
• W2023129208 cites W2115058538 @default.
• W2023129208 cites W2136184219 @default.
• W2023129208 cites W2138534614 @default.
• W2023129208 cites W2146073170 @default.
• W2023129208 cites W2147406493 @default.
• W2023129208 cites W2148578964 @default.
• W2023129208 cites W2322263306 @default.
• W2023129208 cites W2324452376 @default.
• W2023129208 cites W74544974 @default.
• W2023129208 cites W2055935599 @default.
• W2023129208 cites W2107978811 @default.
• W2023129208 cites W2589004289 @default.
• W2023129208 doi "https://doi.org/10.1186/cc6810" @default.
• W2023129208 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2447552" @default.
• W2023129208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18315876" @default.
• W2023129208 hasPublicationYear "2008" @default.
• W2023129208 type Work @default.
• W2023129208 sameAs 2023129208 @default.
• W2023129208 citedByCount "69" @default.
• W2023129208 countsByYear W20231292082012 @default.
• W2023129208 countsByYear W20231292082013 @default.
• W2023129208 countsByYear W20231292082014 @default.
• W2023129208 countsByYear W20231292082015 @default.
• W2023129208 countsByYear W20231292082016 @default.
• W2023129208 countsByYear W20231292082017 @default.
• W2023129208 countsByYear W20231292082018 @default.
• W2023129208 countsByYear W20231292082020 @default.
• W2023129208 countsByYear W20231292082021 @default.
• W2023129208 countsByYear W20231292082022 @default.
• W2023129208 countsByYear W20231292082023 @default.
• W2023129208 crossrefType "journal-article" @default.
• W2023129208 hasAuthorship W2023129208A5003250662 @default.
• W2023129208 hasAuthorship W2023129208A5007794186 @default.
• W2023129208 hasAuthorship W2023129208A5009424802 @default.
• W2023129208 hasAuthorship W2023129208A5010437603 @default.
• W2023129208 hasAuthorship W2023129208A5011364849 @default.
• W2023129208 hasAuthorship W2023129208A5016832904 @default.
• W2023129208 hasAuthorship W2023129208A5029656810 @default.
• W2023129208 hasAuthorship W2023129208A5030817657 @default.
• W2023129208 hasAuthorship W2023129208A5031717153 @default.
• W2023129208 hasAuthorship W2023129208A5035524531 @default.
• W2023129208 hasAuthorship W2023129208A5041418474 @default.
• W2023129208 hasAuthorship W2023129208A5052169179 @default.
• W2023129208 hasAuthorship W2023129208A5058197621 @default.
• W2023129208 hasAuthorship W2023129208A5069466103 @default.
• W2023129208 hasAuthorship W2023129208A5072937016 @default.
• W2023129208 hasAuthorship W2023129208A5079941141 @default.
• W2023129208 hasAuthorship W2023129208A5082527172 @default.
• W2023129208 hasAuthorship W2023129208A5084752934 @default.
• W2023129208 hasBestOaLocation W20231292081 @default.
• W2023129208 hasConcept C119060515 @default.
• W2023129208 hasConcept C120665830 @default.
• W2023129208 hasConcept C121332964 @default.
• W2023129208 hasConcept C126322002 @default.
• W2023129208 hasConcept C141071460 @default.
• W2023129208 hasConcept C159641895 @default.
• W2023129208 hasConcept C188816634 @default.

• next